Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$36.20 Mil
% of Total Estimate Gain
15.09%

RA CAPITAL MANAGEMENT, L.P.'s Axsome Therapeutics Inc Holding Summary

As of 2025-03-31, RA CAPITAL MANAGEMENT, L.P. held - shares of Axsome Therapeutics Inc(AXSM), totaling N/A. This investment constitutes 0% of their stock portfolio, and RA CAPITAL MANAGEMENT, L.P. now holds 0% of the outstanding Axsome Therapeutics Inc(AXSM) stock.

The initial trade took place in 2019Q1. And since then RA CAPITAL MANAGEMENT, L.P. has made 4 purchases of AXSM, at an average price of $40.25, for a total of 5.96 Mil shares. In addition, there have been 6 sales at an average price of $46.32 for 5.96 Mil shares. Based on historical transaction data and AXSM's current price of $108.41, RA CAPITAL MANAGEMENT, L.P.'s estimated gain on his AXSM holdings is $36.20 Mil, reflecting a 15.09% gain to date.

RA CAPITAL MANAGEMENT, L.P. AXSM ($108.41) Holding Chart

RA CAPITAL MANAGEMENT, L.P. AXSM ($108.41) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1